UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 180 filers reported holding UNIQURE NV in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,789 | -75.2% | 25,900 | -58.9% | 0.00% | – |
| Q2 2023 | $700,994 | +136.0% | 63,039 | +279.8% | 0.00% | – |
| Q3 2022 | $297,000 | -9.2% | 16,600 | -6.2% | 0.00% | -100.0% |
| Q2 2022 | $327,000 | -34.2% | 17,700 | -36.3% | 0.00% | – |
| Q1 2022 | $497,000 | -42.5% | 27,800 | +1.4% | 0.00% | – |
| Q3 2021 | $864,000 | +46.7% | 27,414 | +45.3% | 0.00% | -100.0% |
| Q2 2021 | $589,000 | -51.8% | 18,863 | -48.6% | 0.00% | -50.0% |
| Q1 2021 | $1,222,000 | -2.1% | 36,711 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $1,248,000 | +37.4% | 33,581 | +33.1% | 0.00% | -33.3% |
| Q3 2020 | $908,000 | -21.5% | 25,233 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,157,000 | +470.0% | 25,312 | +462.5% | 0.00% | +200.0% |
| Q1 2020 | $203,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |